Adamis Pharmaceuticals Co... (ADMP)
NASDAQ: ADMP
· Real-Time Price · USD
0.78
0.01 (1.50%)
At close: Sep 07, 2023, 9:59 PM
Adamis Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | 3.50 | -0.18 | 61.77 | -1.87 | -1.69 | -2.23 | -2.06 | -2.57 | -2.92 | -4.4 | -1.98 |
PEG Ratio | -0.03 | 0.00 | -0.61 | 0.08 | 0.04 | 0.12 | -0.12 | 0.09 | -0.09 | 0.09 | 0.04 |
PS Ratio | 0.54 | 891.61 | 12.19 | 11.81 | 19.77 | 1.88K | 74.00 | -77.84 | 190.04 | 40.83 | 29.62 |
PB Ratio | -0.00 | -0.52 | -1.83 | -31.42 | 10.46 | 10.66 | 5.37 | 3.49 | 4.19 | 3.51 | 2.20 |
P/FCF Ratio | n/a | -2.41 | -11.45 | -15.74 | -3.86 | -7.32 | -12.18 | -13.08 | -14.57 | -9.49 | -24.62 |
P/OCF Ratio | n/a | -2.41 | -11.45 | -16.68 | -3.97 | -7.59 | -12.23 | -13.52 | -14.79 | -9.74 | -26.82 |
OCF/S Ratio | n/a | -369.84 | -1.07 | -0.71 | -4.98 | -248.32 | -6.05 | 5.76 | -12.85 | -4.19 | -1.1 |
Debt / Equity Ratio | -0.01 | -0.01 | -0.03 | -0.42 | 0.15 | 0.07 | 0.15 | 0.03 | 0.02 | 0.18 | 0.15 |
Quick Ratio | 0.54 | 0.19 | 0.53 | 0.70 | 1.01 | 1.53 | 2.04 | 3.10 | 3.99 | 3.27 | 2.82 |
Current Ratio | 0.58 | 0.23 | 0.58 | 0.81 | 1.14 | 1.58 | 2.05 | 3.14 | 4.56 | 3.43 | 2.94 |
Asset Turnover | 0.00 | 0.00 | 0.16 | 0.20 | 0.12 | 0.00 | 0.04 | -0.03 | 0.02 | 0.06 | 0.05 |
Interest Coverage | 110.81 | -244.09 | -2.48 | n/a | -15.52 | n/a | n/a | n/a | -5.48K | -205.42 | -196.17 |
Return on Equity | n/a | 0.73 | -0.01 | 4.21 | -1.55 | -1.19 | -0.65 | -0.34 | -0.36 | -0.2 | -0.28 |
Return on Assets | n/a | -1.81 | 0.01 | -0.31 | -0.36 | -0.47 | -0.34 | -0.23 | -0.27 | -0.15 | -0.19 |
Return on Invested Capital | n/a | 1.45 | -0.01 | 35.47 | -1.31 | -0.96 | -0.4 | -0.29 | -0.69 | -0.17 | -0.12 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 1.00 | -51.04 | -0.23 | -0.15 | -0.09 | -16.3 | -0.27 | 2.72 | -0.63 | 0.04 | 0.11 |
Net Profit Margin | 0.04 | -1.23K | 0.05 | -1.58 | -2.92 | -210.74 | -8.97 | 7.57 | -16.27 | -2.32 | -3.74 |
Pretax Profit Margin | 0.04 | -1.01K | -6.2 | -1.58 | -2.84 | -209.19 | -8.83 | 6.74 | -6.8 | -2.32 | -3.74 |
Operating Profit Margin | -0.36 | -1.63K | -4.42 | -2.02 | -3.07 | -205.18 | -6.85 | 6.83 | -13.45 | -2.3 | -1.88 |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | -0.36 | -606.68 | -2.65 | -2.17 | -2.61 | -202 | -6.93 | 6.51 | -13.45 | -2.13 | -1.72 |